Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Delivery systems for inhaled nitric oxide

D Hess1, R Ritz, R D Branson

  • 1Massachusetts General Hospital, Boston, USA.

Respiratory Care Clinics of North America
|December 9, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A retrospective analysis of phase I and phase I/II investigator-initiated clinical trials conducted by the Swiss Group for Clinical Cancer Research (SAKK).

ESMO open·2025
Same author

Healthcare-associated infection impact with bioaerosol treatment and COVID-19 mitigation measures.

The Journal of hospital infection·2021
Same author

Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10).

Blood cancer journal·2019
Same author

Vacuum-assisted early transanal closure of leaking low colorectal anastomoses: the CLEAN study.

Surgical endoscopy·2017
Same author

Phase I trial of the oral smoothened inhibitor sonidegib in combination with paclitaxel in patients with advanced solid tumors.

Investigational new drugs·2017
Same author

Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized phase III trial SAKK 22/99.

Annals of oncology : official journal of the European Society for Medical Oncology·2016

Reliable delivery systems are crucial for inhaled nitric oxide (NO) therapy. Ensuring system safety and reliability is essential for effective treatment and avoiding potential hazards.

Area of Science:

  • Medical Devices
  • Respiratory Medicine
  • Pharmacology

Background:

  • Inhaled nitric oxide (NO) is a therapeutic gas with significant clinical applications.
  • The efficacy and safety of NO therapy are heavily dependent on the delivery method.

Purpose of the Study:

  • To emphasize the critical importance of technical aspects in inhaled NO delivery.
  • To highlight the necessity of reliable delivery systems for therapeutic benefit and hazard mitigation.

Main Methods:

  • This study focuses on the practical considerations of inhaled NO delivery systems.
  • It reviews the technical requirements for safe and effective administration.

Main Results:

  • Technical issues in NO delivery are as significant as therapeutic considerations.

Related Experiment Videos

  • Benefits of inhaled NO are only realized with a dependable delivery system.
  • Unreliable systems can exacerbate hazards and toxicity.
  • Conclusions:

    • Clinicians must prioritize the selection and use of safe and reliable inhaled NO delivery systems.
    • Ensuring system integrity is paramount for patient safety and treatment success.